UK Markets close in 3 hrs 47 mins
  • FTSE 100

    7,769.33
    +8.22 (+0.11%)
     
  • FTSE 250

    19,918.20
    +2.69 (+0.01%)
     
  • AIM

    866.73
    +1.32 (+0.15%)
     
  • GBP/EUR

    1.1371
    -0.0018 (-0.16%)
     
  • GBP/USD

    1.2368
    -0.0039 (-0.3117%)
     
  • BTC-GBP

    18,540.98
    -215.04 (-1.15%)
     
  • CMC Crypto 200

    519.69
    -7.50 (-1.42%)
     
  • S&P 500

    4,060.43
    +44.21 (+1.10%)
     
  • DOW

    33,949.41
    +205.57 (+0.61%)
     
  • CRUDE OIL

    82.19
    +1.18 (+1.46%)
     
  • GOLD FUTURES

    1,930.10
    +0.10 (+0.01%)
     
  • NIKKEI 225

    27,382.56
    +19.81 (+0.07%)
     
  • HANG SENG

    22,688.90
    +122.12 (+0.54%)
     
  • DAX

    15,149.99
    +17.14 (+0.11%)
     
  • CAC 40

    7,094.26
    -1.73 (-0.02%)
     

Syndromic Multiplex Diagnostic Global Market Report 2023: Speed of Diagnosis and Lower Costs Drive Adoption

Company Logo
Company Logo

Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization" report has been added to ResearchAndMarkets.com's offering.

The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.

Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?

Syndromic testing is proving itself in the market. Players are reporting double-digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report includes five year market forecasts. In a special section, the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel-based ordering of infectious disease tests.

Key Topics Covered:

1 Market Guides

2 Introduction and Market Definition
2.1 What are Syndromic Multiplex Tests?
2.2 Syndromic Testing - the quiet revolution in diagnostics
2.2.1 Syndromic Testing - more than Panels.
2.3 Market Definition
2.3.1 Multiplex Market Size.
2.3.2 Currency.
2.3.3 Years.
2.4 Methodology
2.4.1 Authors
2.4.2 Sources
2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics

3 The Infectious Diseases - Guide to the Pathogens

4 Industry Overview
4.1 Industry Participants
4.1.1 IVD Supplier
4.1.2 Independent lab specialized/esoteric
4.1.3 Independent lab national/regional
4.1.4 Independent lab analytical
4.1.5 Public National/regional lab
4.1.6 Hospital lab
4.1.7 Physician lab
4.1.8 Audit body
4.2 The Clinical Laboratory Market Segments
4.3 Industry Structure
4.3.1 Hospital Testing Share
4.3.2 Economies of Scale
4.3.3 Physician Office Lab's
4.3.4 Physician's and POCT

5 Market Trends
5.1 Factors Driving Growth
5.1.1 Speed of Diagnosis.
5.1.2 Effect of Syndromic Testing on Costs.
5.1.3 Point of Care Advantage.
5.1.4 Syndrome Testing, Accuracy and Diagnostic Risk
5.1.5 Single Visits.
5.1.6 Improvement in Outcomes.
5.1.7 Impact of the COVID-19 Pandemic.
5.2 Factors Limiting Growth
5.2.1 Lower Prices.
5.2.2 Administration/reimbursement.
5.2.3 Infectious Disease is Declining But..
5.2.4 Wellness Hurts.
5.2.5 Economic Growth improves Living Standards.
5.2.6 Impact of the Pandemic Recession
5.3 Instrumentation and Automation
5.3.1 Instruments Key to Market Share
5.3.2 The Shrinking Machine.
5.3.3 Syndrome Testing Moving to Big Instruments?
5.4 Diagnostic Technology Development
5.4.1 Syndromictrends.com
5.4.2 Comparing Syndrome and Targeted Testing
5.4.3 The Multiplex Paradigm Shift
5.4.4 The Sepsis Testing Market - Bellwether for Syndromics
5.4.5 The Single Visit and AntiMicrobial Resistance
5.4.6 Syndromics drives POCT adoption.
5.4.7 A Big Future for PCR?

6 Syndromic Testing Recent Developments

7 Profiles of Key Syndromic Testing Companies

8 The Global Market for Syndromic Multiplex Diagnostics

9 Global Syndromic Multiplex Markets - By Syndrome
9.1 Respiratory
9.2 Gastrointestinal
9.3 Blood
9.4 Meningitis/Encephalitis
9.5 Sexually Transmitted Disease
9.6 Other Syndrome

10 Global MDx Infectious Disease Markets - by Place
10.1 Hospital Lab
10.2 Outpatient Lab
10.3 Point of Care
10.4 Other Place

11 Global MDx Infectious Disease Markets - by Product
11.1 Instruments
11.2 Cartridges
11.3 Reagents
11.4 Other Product

Companies Mentioned

  • Abacus Diagnostica

  • Abbott Diagnostics

  • Accelerate Diagnostics

  • Ador Diagnostics

  • Akonni Biosystems

  • Alveo Technologies

  • Antelope Dx

  • Applied BioCode

  • Aus Diagnostics

  • Baebies

  • Beckman Coulter Diagnostics

  • Becton, Dickinson and Company

  • Binx Health

  • Bio-Rad Laboratories, Inc

  • Biocartis

  • BioFire Diagnostics (bioMerieux)

  • bioMerieux Diagnostics

  • Bosch Healthcare Solutions GmbH

  • Cepheid (Danaher)

  • Credo Diagnostics Biomedical

  • Cue Health

  • Curetis N.V./Curetis GmbH

  • Diagenode Diagnostics

  • Diasorin S.p.A.

  • Enzo Life Sciences, Inc.

  • Eurofins Scientific

  • Fluxergy

  • Fusion Genomics.

  • Genetic Signatures

  • GenMark Dx (Roche)

  • Hibergene Diagnostics

  • Hologic

  • Immunexpress

  • Inflammatix

  • Invetech

  • Janssen Diagnostics

  • Karius

  • Lexagene

  • LightDeck Diagnostics

  • Lucira Health

  • Luminex Corp

  • Maxim Biomedical

  • Meridian Bioscience

  • Mesa Biotech (Thermo Fisher)

  • Millipore Sigma

  • Mobidiag (Hologic)

  • Molbio Diagnostics

  • Nanomix

  • Novel Microdevices

  • Operon

  • Oxford Nanopore Technologies

  • Panagene

  • Perkin Elmer

  • Primerdesign (Novacyt)

  • Prominex

  • Qiagen Gmbh

  • Quantumdx

  • Quidel

  • Roche Molecular Diagnostics

  • Saw Diagnostics

  • Seegene

  • Siemens Healthineers

  • Sona Nanotech

  • SpeeDx

  • T2 Biosystems

  • Talis Biomedical

  • Thermo Fisher Scientific Inc.

  • Veramarx

  • Visby Medical

  • XCR Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/9kk6r4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900